Anti-human leukocyte antigen immunization after early allograft nephrectomy

Transplantation

Volumn 93, Issue 9, 2012, Pages 936-941

  Del Bello, Arnaud ^a   Congy, Nicolas ^a,b   Sallusto, Federico ^c   Cardeau Desangles, Isabelle ^a   Fort, Marylise ^a   Esposito, Laure ^a   Guitard, Joelle ^a   Cointault, Olivier ^a   Lavayssière, Laurence ^a   Nogier, Marie Béatrice ^a   Game, Xavier ^c   Blancher, Antoine ^a,b   Rostaing, Lionel ^a,d   Kamar, Nassim ^a,d  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Hôpital de Rangueil ^*  (France)

^d CHU PURPAN   (France)

Author keywords

Allograft nephrectomy; Antibodies; Early graft loss; Induction therapy

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DE NOVO HLA ANTIBODY; DONOR SPECIFIC ANTIBODY; EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ALLOGRAFT; ANTIBODY PRODUCTION; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR SELECTION; FEMALE; GRAFT FAILURE; HUMAN; INCIDENCE; MALE; NEPHRECTOMY; OPERATION DURATION; PREDICTION; PRIORITY JOURNAL; REOPERATION;

ANTIBODIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNIZATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHRECTOMY; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84860779696     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31824b3720     Document Type: Article

References (17)

1. Bakir N, Sluiter WJ, Ploeg RJ, et al. Primary renal graft thrombosis. Nephrol Dial Transplant 1996; 11: 140.
2. Aktas S, Boyvat F, Sevmis S, et al. Analysis of vascular complications after renal transplantation. Transplant Proc 2011; 43: 557.
3. Renkens JJ, Rouflart MM, Christiaans MH, et al. Outcome of nonheart-beating donor kidneys with prolonged delayed graft function after transplantation. Am J Transplant 2005; 5: 2704.
4. Lenaers J, Christiaans M, van Heurn E, et al. Frequent but late donordirected antibody formation after kidney transplantectomy within one month after grafting. Transplantation 2006; 81: 614.
5. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3: 665.
6. Terasaki PI, Cai J. Humoral theory of transplantation: Further evidence. Curr Opin Immunol 2005; 17: 541.
7. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008; 8: 324.
8. Ojo A, Wolfe RA, Agodoa LY, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: Multivariate analyses from the United States Renal Data System. Transplantation 1998; 66: 1651.
9. Cecka JM. The UNOS Scientific Renal Transplant Registry. Clin Transpl 1996; 1.
10. Martin L, Guignier F, Mousson C, et al. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003; 76: 395.
11. Khakhar AK, Shahinian VB, House AA, et al. The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome. Transplant Proc 2003; 35: 862.
12. Scornik JC, Kriesche HU. Human leukocyte antigen sensitization after transplant loss: Timing of antibody detection and implications for prevention. Hum Immunol 2011; 72: 398.
13. Sener A, Khakhar AK, Nguan CY, et al. Early but not late allograft nephrectomy reduces allosensitization after transplant failure. Can Urol Assoc J 2011; 5: E142.
14. Del Bello A, Congy N, Sallusto F, et al. Donor-specific antibodies after ceasing immunosuppressive therapy with or without an allograft nephrectomy. Am J Transplant (in press).
15. Bocrie O, Hussein Aly AA, Guignier F, et al. Distribution of donorspecific antibodies in the cortex and the medulla of renal transplants with chronic allograft nephropathy. Transpl Immunol 2007; 17: 227.
16. Adeyi OA, Girnita AL, Howe J, et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol 2005; 14: 53.
17. Phelan PJ, Magee C, O'Kelly P, et al. Immediate re-transplantation following early kidney transplant thrombosis. Nephrology (Carlton) 2011; 16: 607.